プライマリー胆道炎におけるセカンドライン療法としてフェノフィブラートの長期使用:遡及的研究
Mariko Maxwell1, Yanhong Deng2, Bonnie Chen1
1Section of Digestive Diseases and Liver Center, Yale School of Medicine, New Haven, Connecticut, USA.
Alimentary pharmacology & therapeutics
|February 18, 2026
まとめ
フェノフィブラートは, Ursodeoxycholic Acid (UDCA) に反応しないプライマリ胆道胆炎 (PBC) 患者の安全で効果的なセカンドライン治療を提供します. この研究では,フェノフィブラートはコレスタティックマーカーと予後スコアを改善し,費用対効果の高い選択肢であることを示しています.
科学分野:
- 肝臓病理学 肝臓病理学
- 薬理学 薬理学とは
- 内科内科は,内科の内科である.
背景:
- 主発性胆道胆炎 (PBC) は,しばしば,ウルソデオキシコール酸 (UDCA) に対する不完全な反応を示します.
- PPAR-αアゴニストであるフェノフィブラートは,PBCの潜在的なセカンドライン療法です.
- PBCにおけるフェノフィブラートの有効性に関する縦断的なデータは限られている.
研究 の 目的:
- PBC患者のコレスタティックバイオマーカー,予後スコア,および線維症指数に対するフェノフィブラートの長期的な効果を評価する.
- フェノフィブラートは,他のPPARアゴニストに対して,費用対効果が高く,アクセシブルな代替品として評価する.
主な方法:
- フェノフィブラートで治療された59人のPBC患者を対象とした単一センターの遡及コホート研究 (2012-2024).
- アルカリリンファスファテーゼ (ALP) の正常化,GLOBE,UK-PBC,およびFIB-4スコアの分析.
- フェノフィブラートの耐受性の評価と中止の理由.
主要な成果:
- ALPの正常化までの平均時間は,全体で9.5ヶ月,パリ2の基準を満たしていない患者では11.2ヶ月でした.
- GLOBEの予後スコアの有意な改善が観察されました.
- UK-PBCスコアとFIB-4線維症指数は安定したままでした.
- フェノフィブラートはよく耐えており,肝臓酵素値が上昇したため投与中止は5%のみでした.
結論:
- フェノフィブラートは,不十分なUDCA応答を有するPBC患者のコレステリックマーカーと予後スコアを有意に改善しました.
- フェノフィブラートは,好ましい安全性プロファイルを示しています.
- フェノフィブラート (Fenofibrate) は,PBCのための実行可能で,アクセシブルで,手頃な価格のセカンドライン療法です.
さらに関連する動画
関連する概念動画
Chronic Pancreatitis II: Collaborative Care
393
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
393
Ultrasound II: Endoscopic Ultrasound and FibroScan
805
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
805
Chronic Bowel Disorders: Introduction
820
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
820
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
212
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
212
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
259
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
259
Chronic Pancreatitis I: Introduction
762
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
762


